“The global nasal drug delivery technology market is estimated to have reached $44,385 million in 2019” says new Visiongain report

30 March 2020
Pharma

Visiongain has launched a new pharma report Nasal Drug Delivery Technology Market Forecast 2020-2030: Nasal Sprays: Non-Pressurised Containers & Pressurised Containers, Nasal Drops & Liquids, Nasal Gels, Nasal Powders; Multi Dose Nasal Devices, Bi-Dose Nasal Devices, Unit Dose Nasal Devices; Allergic and Non-Allergic Rhinitis, Nasal Congestion, Asthma; Ambulatory Surgery Centres, Hospitals, Specialty Clinics, Vaccination Centres.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 185-page report you will receive 47 tables and 54 figures- all unavailable elsewhere.

The 185-page report provides clear detailed insight into the global nasal drug delivery technology market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Nasal Drug Delivery Technology Market forecasts from 2020-2030

• Global Nasal Drug Delivery Technology Market forecasts from 2020-2030 by Dosage Form:
• Nasal Sprays
• Non-Pressurized Containers
• Pressurized Containers
• Nasal Drops & Liquids
• Nasal Gels
• Nasal Powders

• Global Nasal Drug Delivery Technology Market Forecast 2020-2030 by System:
• Unidose Nasal Devices
• Bi-dose Nasal Devices
• Multi dose Nasal Devices

• Global Nasal Drug Delivery Technology Market forecasts from 2020-2030 by Application:
• Allergic and Non-Allergic Rhinitis
• Nasal Congestion
• Asthma

• Global Nasal Drug Delivery Technology Market forecasts from 2020-2030 by End User:
• Ambulatory Surgery Centers
• Hospitals
• Specialty Clinics
• Vaccination Centers

• Revenue forecasts for the Nasal Drug Delivery Technology Market by Regional and National Market from 2020-2030:
• North America: US, Canada, Mexico
• Latin America: Brazil, Mexico, Rest of Latin America
• Western Europe: Germany, UK, Italy, France, Spain, Nordic, Benelux, Rest of o Western Europe
• Eastern Europe: Russia, Poland, Rest of Eastern Europe
• Asia-Pacific: Japan, China, India, Australia & New Zealand, ASEAN, Rest of Asia-Pacific
• MEA: GCC Countries, South Africa, North Africa, Rest of MEA

The revenues forecast of each regional market is further broken down by wound type, product type, and end-user.

• Profiles and discussion on the leading companies of the nasal drug delivery technology market:
• 3M Company
• Becton, Dickinson and Company
• GlaxoSmithKline plc
• Johnson & Johnson
• Merck & Co., Inc.
• Pfizer Inc.
• Teleflex Incorporated
• Naveh Pharma Ltd.
• OptiNose US, Inc.
• Pendopharm
• AptarGroup, Inc.

• Analysis of the Drivers, Restraints, Opportunities and Trends of the wound care management market.

• Key Questions Answered by this Report:
• How is the nasal drug delivery technology market evolving?
• What is driving and restraining nasal drug delivery technology market dynamics?
• How will each nasal drug delivery technology submarket segment grow over the forecast period and how much Sales will these submarkets account for in 2030?
• How will market shares of each nasal drug delivery technology submarket develop from 2020-2030?
• Which individual technologies will prevail and how will these shifts be responded to?
• Which nasal drug delivery technology submarket will be the main driver of the overall market from 2020-2030?
• Will leading national nasal drug delivery technology markets broadly follow macroeconomic dynamics, or will individual country sectors outperform the rest of the economy?
• How will market shares of the national markets change by 2030 and which nation will lead the market in 2030?
• Who are the leading players and what are their prospects over the forecast period?
• How will the sector evolve as alliances form during the period between 2020 and 2030?

Visiongain's study is intended for anyone requiring commercial analyses for the Global Nasal Drug Delivery Technology Market. You find data, trends and predictions.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Healthcare Cold Chain Logistics Market Report 2020-2030

. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.

16 September 2020

Read

Visiongain Publishes Vaccines Sales Market Report 2020-2030

Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.

14 September 2020

Read

Visiongain Publishes Ophthalmic Ultrasound Systems Market Report 2020-2030

The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.

09 September 2020

Read

Visiongain Publishes Drug Discovery Outsourcing Market Report 2020-2030

The current COVID-19 pandemic is anticipated to have a minor impact on the overall outsourcing business outlook for global drug discovery. Also, significant growth during the COVID-19 pandemic is expected to be seen in the outsourcing of drugs and medicines needed to treat COVID-19 infections.

07 September 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever